Viewing Study NCT01441635

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:20 PM
Ignite Modification Date: 2026-01-05 @ 5:51 PM
Study NCT ID: NCT01441635
Status: COMPLETED
Last Update Posted: 2021-07-13
First Post: 2011-09-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heavy Uterine Bleeding View
None Uterine Fibroids View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Uterine Fibroids View
None Heavy Uterine Bleeding View
None Elagolix View
None Menorrhagia View
None ABT-620 View
None Leiomyomata View
None Elagolix sodium View